# UROGEN PHARMA LTD (URGN)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/URGN/

- Reporting holders: 2
- Reported value: $30.3K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $27.0K | 664 | 0.0% | 11 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $3.3K | 82 | 0.0% | 12 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $30.3K |
| Q2 2026 | 192 | $1.6B |
| Q1 2026 | 172 | $845.2M |
| Q4 2025 | 170 | $1.1B |
| Q3 2025 | 165 | $951.3M |
| Q2 2025 | 154 | $606.5M |
| Q1 2025 | 139 | $463.0M |
| Q4 2024 | 139 | $387.4M |
| Q3 2024 | 127 | $448.7M |
| Q2 2024 | 116 | $649.2M |
| Q1 2024 | 113 | $421.0M |
| Q4 2023 | 106 | $329.0M |